Kezar Life Sciences, Inc. (KZR): Price and Financial Metrics
KZR Price/Volume Stats
| Current price | $4.88 | 52-week high | $9.27 |
| Prev. close | $4.92 | 52-week low | $4.54 |
| Day low | $4.54 | Volume | 33,800 |
| Day high | $4.97 | Avg. volume | 31,017 |
| 50-day MA | $5.98 | Dividend yield | N/A |
| 200-day MA | $6.53 | Market Cap | 35.65M |
KZR Stock Price Chart Interactive Chart >
Kezar Life Sciences, Inc. (KZR) Company Bio
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Its lead product candidate, KZR-616, a selective immunoproteasome inhibitor that is in Phase 1b/2 clinical trials in lupus and lupus nephritis The company was incorporated in 2015 and is headquartered in South San Francisco, California.
KZR Price Returns
| 1-mo | -14.54% |
| 3-mo | N/A |
| 6-mo | -40.89% |
| 1-year | -46.96% |
| 3-year | -97.12% |
| 5-year | -87.32% |
| YTD | -27.38% |
| 2024 | -29.07% |
| 2023 | -86.54% |
| 2022 | -57.89% |
| 2021 | 220.31% |
| 2020 | 30.17% |
Loading social stream, please wait...